← Back to catalogue

PathVysion

FDA UDI

Class II (US FDA UDI)

by Abbott Molecular

Identity

Trade Name
PathVysion FDA UDI
Generic Name
Human epidermal growth factor receptor 2 (HER2) protein IVD, control FDA UDI
Device Name
ProbeChek PathVysion HER-2/neu Cut-Off Control Slides FDA UDI
Model / Reference
02J04-030 FDA UDI
Description
ProbeChek PathVysion HER-2/neu Cut-Off Control Slides FDA UDI

Identifiers

Catalog Number
02J04-030 FDA UDI
Primary DI / UDI-DI
00884999001831 FDA UDI
FDA Product Code
OYU FDA UDI
GMDN Term
Human epidermal growth factor receptor 2 (HER2) protein IVD, control FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.4700 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Human epidermal growth factor receptor 2 (HER2) protein IVD, control

PathVysion by Abbott Molecular — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Human epidermal growth factor receptor 2 (HER2) protein IVD, control.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Abbott Molecular

Sources (1)

  • FDA UDI 95db23b5-dd7e-4388-aec8-30a821b1e7e2 36 fields · synced May 31, 2026